A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid Tumors
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the tolerability and safety of HKI-272, and to
determine the maximum dose that can safety be given. The secondary purpose of this study is
to determine how the body uses and gets rid of HKI-272 and to assess whether HKI-272 is
effective for the treatment of advanced solid tumors.